Predictive Value of β2-microspheres for Postoperative Delirium
The Predictive Value of β2-microspheres for Postoperative Delirium in the Elderly After Orthopedic Surgery
1 other identifier
observational
184
1 country
1
Brief Summary
This study evaluated the predictive value of β2-microspheres for postoperative delirium (POD) in the elderly after orthopedic surgery. For this purpose, the levels of β2-microspheres in plasma and cerebrospinal fluid were compared between the POD and non-POD groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 15, 2017
CompletedFirst Posted
Study publicly available on registry
April 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2017
CompletedDecember 27, 2018
December 1, 2018
2.2 years
April 15, 2017
December 24, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of POD
The patients were interviewed one day before the surgery and on postoperative days 1-3 by the Confusion Assessment Method and then divided them into POD and non-POD groups.
4 days
Secondary Outcomes (1)
The levels of β2-microspheres in plasma and cerebrospinal fluid
1 day
Study Arms (2)
POD group
POD group refers to the patients who were diagnosed to be delirious by the Confusion Assessment Method.
Non-POD group
Non-POD refered to the patients who did not become delirious by the Confusion Assessment Method.
Eligibility Criteria
Patients aged ≥65 years undergoing orthopedic operations under spinal anesthesia were investigated.
You may qualify if:
- ≥65 years old, American Standards AssociationⅠ-Ⅲ, undergoing orthopedic operations under spinal anesthesia
You may not qualify if:
- decline to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhongda Hospitallead
Study Sites (1)
Zhongda Hospital
Nanjing, Jiangsu, 210009, China
Biospecimen
plasma and cerebrospinal fluid
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jian-jun Yang
Zhongda Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Department of Anesthesiology
Study Record Dates
First Submitted
April 15, 2017
First Posted
April 26, 2017
Study Start
October 1, 2015
Primary Completion
December 30, 2017
Study Completion
December 30, 2017
Last Updated
December 27, 2018
Record last verified: 2018-12
Data Sharing
- IPD Sharing
- Will not share